Upregulation of FCN1 potentially enhances immune cell activation (e.g., CD4 T cells, CD8 T cells, NK cells, Th1 cells, and MDSC) and their infiltration into tumors by modulating the expression of chemokines, their receptors, and cell adhesion molecules in the tumor microenvironment. This evidence concerns the gene CD8A and neoplasm.